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Bullous pemphigoid is characterized by the dermal 
infiltration of lymphocytes, which precedes the striking 
influx of eosinophils as the lesion evolves into the bullous 
phase. This finding prompted a search for chemoattrac-
tant activity for lymphocytes in the blister fluid of un-
treated individuals with bullous pemphigoid. We found 
such activity in the bullous fluids of 6 consecutive pa-
tients but not in a patient with pemphigus vulgaris. This 
lymphocyte chemoattractant activity separates into 4 
peaks upon Sephadex G-100 chromatography and the 
peak of 56,000 daltons was further evaluated. Upon 
quaternary aminoethyl Sephadex-anion exchange chro-
matography this peak elutes at 4-8 ms and with prepa-
rative isoelectric focusing it demonstrates an isoelectric 
point of 8.6-9.0. This activity was susceptible to deg-
radation by trypsin and neuraminidase, but was stable 
upon heating to 56°C for 30 min. Its chemoattractant 
activity is predominantly chemokinetic by checker-
board analysis. As defined by chromatography, stabil-
ity, and functional characteristics, this activity is simi-
lar to a recently described human lymphocyte chemoat-
tractant lymphokine. This finding suggests that prod-
ucts of activated lymphocytes are present in blister 
fluids of patients with bullous pemphigoid and may con-
tribute to the early influx of lymphocytes in this disease. 
Bullous pemphigoid is a disease characterized by blisters that 
form at the dermal-epidermal junction [ 1]. Affected individuals 
have a serum antibody directed against a basement membrane 
antigen [2- 4] and complement deposition along the basement 
membrane [5- 7]. The identification of activated complement 
proteins and complement-derived neutrophil chemotactic ac-
tivity in blister fluids and of the deposition of the third com-
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Abbreviations: 
BSA: bovine serum albumin 
C3: th ird component of complement 
hpf: high-powered field(s) 
LCA: lymphocyte chemoattractant activity(ies) 
M199: Medium 199 
M199-BSA: Medium 199 plus 0.4% bovine serum albumin 
PBS: phosphate-buffered saline 
QAE Sephadex: quaternary aminoethyl Sephadex 
ponent of complement (C3) along the basement membrane has 
led to the assumption that complement activation participates 
in the pathogenesis of the process [5]. This assumption is 
further supported by the characterization of functional, com-
plement-fixing immune complexes in the diseased skin [8] and 
the in vitro demonstration of dermal-epidermal separation 
caused by the action of pemphigoid antibodies on normal 
human skin in the presence of complement and normal leuko-
cytes [9] . The presence of presumptive mast cell-derived chem-
otactic activity for eosinophils in bullous fluid along with the 
demonstration of degranulated skin mast cells in the dermis 
has implicated the mast cell as a potential participating inflam-
matory cell either directly or, more likely, through the attrac-
tion of eosinophils, which are strikingly prominent as the 
bullous lesion develops [2,10- 12]. However, rather than the 
eosinophil, the lymphocyte is the earliest infiltrating cell into 
the dermis [10]. This observation led us to a preliminary 
demonstration of lymphocyte chemoattractant activity (LCA) 
in bullous pemphigoid blister fluids [13]. 
In this study, a LCA in bullous pemphigoid blisters has been 
characterized as being physicochemically identical to a recently 
described human lymphocyte chemoattractant lymphokine 
[14,15] . It has a Mr of 56,000 by molecular sieve chromatogra-
phy and is a cationic sialoprotein as evidenced by an isoelectric 
point of 8.6-9.0 and susceptibility to inactivation by trypsin 
and neuraminidase. The evidence that t his product of activated 
lymphocytes is present in blister fluids of individuals with 
bullous pemphigoid may partially account for an early patho-
logic abnormality observed during assembly of the bullous 
pemphigoid lesion, namely the accumulation of lymphocytes. 
MATERIALS AND METHODS 
Medium 199 (M199) (Microbiological Associates, Bethesda, Mary-
land); bovine serum albumin (BSA) (Miles Laboratory, Inc., Elkhart, 
Indiana ); Sartorius nitrocellulose 8-!Lm micropore filters (Sa rtorius 
Filters, Inc., Cherry Hill, New Jersey); polystyrene chemotactic cham-
bers (Adaps Corp, Bedford, Massachusetts); ampholytes pH 3-10 (Bio-
Rad Laboratories, Rockville Centre, New York) ; Ficoll-Paque, Sepha-
dex G-100, and quaternary aminoethyl Sephadex (QAE Sepluidex), 
(Pharmacia Fine Chemicals, Piscataway, New J ersey); Sprague-Dawley 
rats (Gofmoor Farms, Westboro, Massachusetts) ; nylon wool (Fenwal 
Laboratories, Division of Travenol Laboratories, Inc., Deerfield, Illi -
nois); and neuraminidase and tryps in (Sigma Chemical Co., St. Louis, 
Missouri) were obtained from the manufacturers and suppliers. 
Patient Population 
The blister fluids of 6 patients with bullous pemphigoid, diagnosed 
by characteristic clinical appearance and by biopsies t hat showed 
typical changes on light microscopy and linear deposits of C3 at the 
epidermal-basement membrane zone as detected by immunofluores-
cence analysis, were studied. All patients were hospitalized and treated 
with saline compresses; some received antihistamines to control prur-
itus. None had received corticosteroids at the time that blister fluids 
were obtained. Blister fluids were aspirated from intact bullae in a 
sterile fashion in to 10-ml syringes containing 1.0 ml acid citrate, pH 
5.2, to serve as an anticoagulant. The cellular contents were removed 
by centrifugation a nd used in other studies. Blister fluids were stored 
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at 70'C in 1-ml portions until assessed for LCA. The histopathologic 
a nd immunopathologic descriptions of uninvolved skin , erythematous 
macules, plaques, and bullae of 5 of these patients have been described 
previously [10] . The blister fluid of a patient wit h typical pemphigus 
vulgaris was collected and stored in a similar ma nner. Blood from a 
n ormal voluntee r was collected in acid cit rate fo r use as a source of 
plasma. 
L y mphocyte M igration 
LCA was assessed by means of a modificat ion [16] of a Boyden 
c ha mber [17] technique. Briefly, lymphocytes to be employed as t he 
r esponding cell pool were obta ined from t he spleens of Sprague-Dawley 
r ats. Spleens were teased apart wit h surgical fo rceps on plastic dishes 
t o permit adherence of monocytes. The nonadherent cells were cent ri -
fuged on Ficoll-Paque cushions: and t he mononuclear cells at t he 
interface were aspireted, washed twice in M199, and suspended at a 
concent ration of 4 X 106 cells/ml in M199 plus 0.4% BSA (M199-BSA) . 
This cell suspension was rout inely 95% lymphocytes as assessed by 
light microscopic evaluation of smears stained wit h Wright 's, Giemsa's, 
o r esterase stains. 
T o determine t he LCA in any experimenta l sample, 4 X 106 lympho-
cytes in 1 ml M199-BSA were placed in the upper compartments of 
c hemotactic chambers that ut ilized 8-11m nitrocellulose micropore fil -
t ers to separate t he cells from 1 ml of M199-BSA alone (cont rol) or of 
M199-BSA containing experimenta l samples. T o different iate chemo-
kinesis from chemotaxis, checkerboard analyses were performed in 
which experimental factors were in t roduced in varying concentrat ions 
into the lower compart ment only, into both compartments, or into the 
upper compartment only of chemotactic cha mbers [18]. Migration 
experiments were ca rried out for 3 h at 37'C in a 5% C0 2 moist 
atmosphere. The filters were fixed, stained, dehydrated, a nd mounted 
according to standa rd histologic methods. Lymphocyte movement was 
quant itated by count ing t he total number of cells migrat ing beyond a 
distance of 50 1-1m at l0-11m interva ls in 5 high-powered fields (hpf) in 
duplicate micropore fil te rs. Results were calculated as mean cells/hpf 
± S.E. Significance of data was determined by ana lysis of variance. For 
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FIG 1. Lymphocyte migratory response to varying dilut ions of the 
blister fluids of 6 patients wit h bullous pemphigoid (0- - -0, • - - - • , 
0 ---0 , • -- - • , X-- -X,&---&) , 1 patient wit h pemphigus vulgaris 
(+--+) , and normal huma n plasma (6--Ll.) placed in the lower 
compartment only of chemotactic chambers. Data a re expressed as a 
mean percent of migrat ion ± SE in response to cont rol buffer alone 
(100%, horizontal line ) which ranged from 8.9 to 12.1 cells/hpf. The 
fluids from each patient were assessed 3 different t imes. The shaded 
area represents t he mean migration in response to cont rol buffer ± 2 
SE. 
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FIG 2. Lymphocyte migratory response to blister fluids of patients 
1 (0- - - 0), 2 (0 - - - 0 ) a nd 3 (X- - -X ) from Fig 1 afte r Sephadex 
G-100 chromatography. Data are expressed as a mean percent of cont rol 
migration ± SE (100%, horizontal line ) which was 8.2 cells/hpf for the 
assay of patient 1; 9.1 cells/hpf fo r patient 2; and 10.2 cells/hpf for 
patient 3. The percents of bed volume are expressed on the abscissa.. 
The shaded area represents t he mean migration in response to cont rol 
buffer ± 2 SE. 
t he convenience of comparison among experiments, data were ex-
pressed as a percentage of migration relative to control condit ions; 
however, t he base line migration of cells/hpf is also noted for each 
experiment in the figure legends. All statistical analyses were performed 
on t he raw data [19]. 
Chromatography 
The chromatographic characterization of LCA from blister fluids 
was performed in an ident ical fashion to t hat previously described fo r 
the purification of lymphotactic lymphokines from human peripheral 
blood lymphocytes stimulated with concanavalin A [15]. Sephadex G-
100 chromatography was perfo rmed at 4'C in a 1.5 x 90 em column 
eluted wit h phosphate-buffered saline (PBS), pH 7.4, at 15 ml/min . 
Two-millili te r fractions were collected in plastic tubes. A 100-1'1 sample 
of every other fraction was placed in t he lower cha mber only of a 
chemotactic chamber, and t he samples were assessed fo r chemoattrac-
tant activity for rat splenic lymphocytes. Fractions wi th chemoattrac-
tant activity were pooled a nd dialyzed against a 0.01 M phosphate 
buffer, pH 7.8. This pooled material was then applied to a 4-ml QAE 
Sephadex-anion exchange column equilibrated in t he same buffer, 
washed wit h 2 bed volumes of buffe r, and eluted wit h a linear 200-ml 
salt gradient to 1 M NaCl at 4 'C. Four-millili ter fractions were collected 
and separately dialyzed against PBS, pH 7.4. Two hundred -microlite r 
port ions of each fraction were then evaluated for chemoattractant 
activity in duplicate. Fractions with chemoattractant activity were 
pooled, dialyzed against distilled water, lyophilized to effect a 10-fold 
concent ration, and subjected to isoelectric focusing in sucrose wi th a 
Buchler apparatus (Fort Lee, New J ersey). T wenty-millilite r (10-40% 
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sucrose) gradients were generated with a Buchler gradient maker and 
a constant-flow pump containing ampholytes in the 3- 10 pH range. 
One-milliliter fractions were eluted with a peristaltic pump, assessed 
for pH, and dialyzed against PBS, pH 7.4, for 24 h at 4•c to remove 
ampholytes and sucrose; a 250-,ul sample of each fraction was placed 
in the lower compartment of duplicate chemotactic chambers and 
assessed fo r LCA. 
RESULTS 
Blister fluids from 6 consecutive patients were assessed for 
the presence of LCA by placing varying concentrations of 
anticoagulated f1uids in the lower chamber of modified Boyden 
chambers (Fig 1). At a concentration of 1:100,000, no activity 
could be detected in any of the fluids. Increasing doses resulted 
in the expression of measurable LCA in each fluid over a wide 
concentration range. However, high concentrations (greater 
than 1:100) frequently resulted in an inability to measure the 
LCA. No LCA was present in plasma at similar dilutions; at 
concentrations of 1:100 or more a slight inhibitory effect was 
seen, similar to that noted with the blister fluids. Serial dilu-
tions of blister fluid from a patient with typical pemphigus 
vulgaris (Fig 1) or from suction-induced blisters contained no 
activity. The fluid from a patient with contact dermatitis did 
contain significant amounts of LCA (data not shown). 
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FIG 3. Sephadex QAE-anion exchange chromatography of lympho-
cyte chemoattractant act ivity in t he Sephadex G-100 peak II from Fig 
2 of patients 1, 2, and 3. Data are expressed as a mean percent of 
control migration ± SE (100%, horizontal line) which was 7.9 cells/hpf 
for the assay for patient 1, 13.2 cells/hpf for patient 2 and 10.1 cells/ 
hpf for patient 3. The linear salt gradient (e____.) is expressed in mS; 
fraction numbers are shown on the abscissa. The shaded area represents 
the mean migration in response to control buffer ± 2 SE. 
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FIG 4. Isoelectric focusing of lymphocyte chemoattractant activity 
in the Sephadex QAE 4- 8 ms peak from Fig 3 of patients 1 and 3. Data 
a re expressed as a mean percent of control migration ± SE (100%, 
horizontal line) which was 13.4 cells/ hpf for the assay for patient 1 and 
10.6 cells/hpf for patient 3. The pH (e____.) of each fraction is 
depicted by the diagonal line. Fraction numbers are shown on the 
abscissa. The shaded area. represents the mean migration in response 
to control buffer ± 2 SE. 
In order to characterize the LCA further, 1.5-ml portions of 
bullous fluid from 3 of the 6 patients were separately subjected 
to Sephadex G-100 chromatography (Fig 2). This chromatog-
raphy resulted in the identification of 4 distinct regions of LCA: 
the first filtered near the void volume; the second and third 
corresponded to Mrs of 56,000 and 25,000-30,000, respectively; 
and the last filtered near the bed volume. Plasma and pemphi-
gus vulgaris blister fluid were also subjected to Sephadex G-
100 chromatography to make certain that the absence of activ-
ity noted with serial dilutions was not due to the simultaneous 
presence of inhibitors. No LCA was uncovered by this maneu-
ver. The region of LCA that eluted between the BSA and 
ovalbumin markers (peak II, 56,000 daltons) was further char-
acterized for comparison with a lymphokine of similar size 
generated from human lymphocytes by antigens or mitogens 
[14,15). 
Fig 3 depicts the QAE Sephadex-anion exchange chromatog-
raphy of the second Sephadex G-100 peak of LCA from each 
of the 3 patients. The LCA eluted with application of the salt 
gradient, corresponding to an ionicity of 4-8 ms. The G-100 
fraction from the bullous f1uid of patient 3 had a second smaller 
peak of activity that eluted from QAE at 18 ms. The active 
fractions from the 4-8 ms region of each fluid were pooled, 
dialyzed, and subjected to isoelectric focusing in sucrose with 
ampholytes in the 3-10 pH range. The results obtained with 
fluids from patients 1 and 3 are displayed in Fig 4; assayable 
activity was identified in fractions corresponding to an isoelec-
tric poirt at 8.6- 9.0. Patient 2 had insufficient activity to be 
measured after focusing. 
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TABLE I. Checkerboard analysis of lymphocyte chemoattractant activity (LCA) purified through the QAE Sephadex step 
Microli te rs of LCA 
below filter 
0 
25 
50 
100 
200 
0 
100" 
98 ± 10 
116 ± 14 
172 ± 15b 
205 ± 14b 
25 
121 ± 13 
126 ± 10 
Micro li ters of LCA above fi lter 
50 100 200 
171 ± l4b 210 ± 12b 228 ± 16" 
181 ± 9" 
219 ± 12b 
232 ± lOb 
a Values represent % of control migration ± SE, where control ranged from 7.5-8.8 cells/high-powered fie ld in 3 experiments with LCA from 
patients 1, 2, and 3. 
b Differe nt from controls, p < 0.05. 
TABL E II. Chemical stability of lymphocyte chemoattractant act1:uity 
(LCA) purified through the QAE Sephadex step 
Buffe r control 
LCA (200 J.L l) 
LCA + heat (56.C; 30 min ) 
LCA + neuram inidase no-• M)' 
LCA +trypsin (10-6 M )d 
100" 
199 ±lOb 
201 ± g• 
105 ± 11 
96 ± 8 
" Values represent % of control migration ± SE where control ranged 
from 9.8- 13.4 cells/high-powered field in 6 experiments- 2 each from 
patients 1, 2, and 3. 
• Different fro m control, p < 0.05. 
' Neuraminidase (lo-• M) corresponds to 0.04 un its/ml incubated 
with 200 Ill LCA fo r 30 min at 37•c before chemotactic assay. 
d T rypsin (10-6 M ) corresponds to 2. 1 units/ml incubated with 200 
Ill LCA for 30 min at 37•c; excess soybean trypsin inactivator was 
added at end of incubation before chemotactic assay. 
T he averaged results of t he checkerboard analyses of t he 
LCA from patients 1, 2, and 3 after Sephadex G-100 (peak II) 
a nd QAE Seph~dex -anion excha nge (4-8 ms) chromatography 
are presen ted in Table I. Lymphocyte migration is stimulated 
when port ions of active QAE fractio ns a re placed in eit her t he 
cell compartment or t he lower compart men t. S ince migration 
appears to be stimulated to a greater exte nt when t he active 
fractions a re incubated wit h t he cells, t he chemoattractant 
activity is predominantly chemokinetic. Furt her cha racteriza-
t ion (Table II) of simila rly enriched chemoattractant activity 
(after Sephadex G-100 and QAE chromatography) from pa-
tien ts 1, 2, and 3 demonstrated it to be stable upon heating to 
56"C fo r 30 min , but suscept ible to biologic inactivation by 
trypsin (10-6 M) and neuraminidase (1o- • M). 
DISCUSSION 
A LCA t hat is present in t he blister fluid of unt reated patients 
wit h bullous pemphigoid (Fig 1) has been isolated and charac-
terized as a 56,000-da lton cationic protein wit h a n isoelectric 
point of 8.6-9.0 (Figs 2-4). T his activity is predominant ly 
chemokinetic in nature (Table 1) , is resistant to degradation by 
heat, and is sensit ive to t rypsin a nd neuraminidase t rea t ment 
(Table II) . By physicochemical a nd functional criteria, t his 
activity is ident ical in each respect to a recent ly described 
human lymphotactic lymphokine [15,16] t hat is generated in 
cult ure by incubation of huma n peripheral blood lymphocytes 
wit h a nt igen , concanavalin A, or phytohemaglut inin. 
The Sephadex G-100 molecular sieve chromatography re-
veals addi t ional LCA p resent in t he bullous flui d (Fig 2) . S ince 
LCA have been ident ified from mast cells [20], macrophages 
[21], and complement activation [22], a ll of which may be 
importan t in t he pathologic p rocess of bullous pemphigo id, 
t hese other LCA could be from a ny of t hese sources. N one of 
these other LCA have been characterized sufficiently fo r com-
parison wit h t he activi t ies present in t he bullous fluids. Any of 
t hese LCA might represent t he ini t iating stimulus for t he early 
lymphocytic infil t rate in bullous pemphigoid, or a lternatively 
may represen t a product of one of t he inflammatory systems 
secondarily activated in t his disease. T he p resence of a lym-
phokine, fo r example, may be a result of lymphocyte activation 
by products of tissue mast cells s imila r to t hose t hat a re of 
basoph il origin (23] or t hat arise from activated complemen t 
components [24]. 
T he recognit ion of a putative lymphokine in b lister fl uids of 
patients wit h bullous pemphigoid suggests t hat other p roducts 
of activated lymphocytes may a lso be p resent . In fact, a colon y 
stimulating facto r-like activity fo r eosinophils has recent ly been 
reported to be present in bullous pemphigoid blister fluids 
[25]. T he fi nding of lymp hokines in blister fl uids, t he obser-
vation in one study t hat t he mononuclear cells of 6 of 7 patients 
wit h bullous pemphigoid p roduced macrophage migration in-
h ibitory factor in response to autologous epidermal extracts 
(26], and t he demonstration t hat lymp hocytes are t he earliest 
infi lt rating cells in a prebullous site [10,13] suggest a role for 
lymphocyte-mediated hypersensitivity in t he pathogenesis of 
bullous pemphigoid. 
T he authors wish to thank Laurie Beardsley fo r typing the manu-
script. 
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Epidermal Cell-Induced Generation of Cytotoxic T-Lymphocyte 
Responses Against Alloantigens or TNP-Modified Syngeneic Cells: 
Requirement for !a-Positive Langerhans Cells* 
HUBERT PEHAMBERGER, M.D., LAURA A. STINGL, A.B., STEPHANIE POGANTSCH, GEORG STEINER, 
KLAUS WOLFF, M.D., AND GEORG STINGL, M.D. 
Department of Dermatology I, University of Vienna Medical School, Vienna, Austria 
The role of epidermal cells (EC) in the activation ofT-
cell proliferation is well established. In this study we 
asked whether EC can provide a stimulus resulting in 
the generation of genetically restricted T-cell cytotox-
icity. For this purpose, C57Bl/6 or C3H/He highly pur-
ified, accessory cell-depleted responder splenic T lym-
phocytes, were stimulated in· 5-day cell-mediated cyto-
toxicity cultures with mitomycin C-treated allogeneic 
or trinitrophenyl (TNP)-modified syngeneic EC, or, for 
control purposes, with unfractionated spleen cells (SC). 
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Abbreviations: 
C': complement 
CML: cell-mediated lympholysis 
CTL: cytotoxic C lymphocyte(s) 
EC: epidermal cell (s) 
FCS: fetal calf serum 
FITC: fluorescein isothiocyanate 
LC: Langerhans cell(s) 
NMS: normal mouse serum 
SC: spleen cell(s) 
TNBS: 2,4,6-trinitrobenzenesulfonic acid 
TNP: trinitrophenyl 
Untreated and complement (C')-treated EC induced 
strong cytotoxic T lymphocyte (CTL) activity in highly 
purified allogeneic T cells and, in analogy, TNP-modi-
fied EC led to the generation of TNP-self CTL, as tested 
in 4 -h 51 Cr release assays against allogeneic or TNP-
modified syngeneic EC or SC targets. These cytotoxic 
responses were comparable in magnitude to those seen 
with allogeneic or TNP-modified syngeneic SC stimu-
lators. In contrast, alloreactive or TNP-self CTL re-
sponses were not generated when stimulating EC were 
depleted of Langer hans cells by pretreatment with anti-
Ia monoclonal antibodies plus C' or, for control .pur-
poses, when highly purified T-cell stimulators were 
used. 
These results demonstrate that EC induce the gener-
ation of alloreactive and TNP-self CTL in the absence 
of Ia-positive splenic accessory cells and that !a-bearing 
Langer hans cell are required for this process to occur. 
In the recent past it has been clearly shown that epidermal 
cells (EC), consisting of keratinocytes, melanocytes, and Lan-
gerhans cells (LC), can initiate cutaneous immune reactions. 
This is particularly true for LC. These dendritic cells comprise 
a small population (3-8% ) of all EC, originate from a bone 
marrow-derived precursor, bear Fc-IgG and C3b receptor sites, 
synthesize Ia antigens, and are critically needed for EC-induced 
antigen-specific, allogeneic and mitogenic (L. A. Sting!, unpub-
lished observation) T -cell proliferative responses (reviewed in 
[1]). Furthermore, murine EC induce the generation of cyto-
toxic T lymphocytes (CTL). This has been reported for allo-
